Determination of olprinone in human plasma utilizing liquid chromatography tandem mass spectrometry

J Pharm Biomed Anal. 2011 Jan 5;54(1):198-202. doi: 10.1016/j.jpba.2010.07.016. Epub 2010 Jul 29.

Abstract

A sensitive and rapid method was developed for quantification of olprinone in human plasma utilizing liquid chromatography tandem mass spectrometry (LC-MS/MS). An aliquot of 1 mL plasma sample was extracted with ethyl acetate-dichloromethane. Separation of olprinone and the milrinone (internal standard, IS) from the interferences was achieved on a C(18) column followed by MS/MS detection. The analytes were monitored in the positive ionization mode. Multiple reaction monitoring using the transition of m/z 251 → m/z 155 and m/z 212 → m/z 140 was performed to quantify olprinone and IS, respectively. The method had a total chromatographic run time of 3 min and linear calibration curves over the concentration range of 0.5-60 ng/mL. The lower limit of quantification (LLOQ) was 0.5 ng/mL. The intra- and inter-day precisions were less than 16.3% for low QC level, and 7.1% for other QC levels, respectively. The intra- and inter-day relative errors were ranged between -12.2% and 3.7% for three QC concentration levels. The validated method was successfully applied to the quantification of olprinone concentration in human plasma after intravenous (i.v.) administration of olprinone at a constant rate of infusion of 2 μg/(kg min) for 5 min in order to evaluate the pharmacokinetics.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetates / chemistry
  • Calibration
  • Chemistry Techniques, Analytical
  • Chemistry, Pharmaceutical / methods
  • Chromatography, Liquid / methods*
  • Humans
  • Imidazoles / analysis
  • Imidazoles / blood*
  • Imidazoles / pharmacokinetics*
  • Ions
  • Methylene Chloride / chemistry
  • Phosphodiesterase 3 Inhibitors / analysis
  • Phosphodiesterase 3 Inhibitors / blood*
  • Phosphodiesterase 3 Inhibitors / pharmacokinetics*
  • Pyridones / analysis
  • Pyridones / blood*
  • Pyridones / pharmacokinetics*
  • Quality Control
  • Reproducibility of Results
  • Spectrometry, Mass, Electrospray Ionization / methods
  • Tandem Mass Spectrometry / methods*

Substances

  • Acetates
  • Imidazoles
  • Ions
  • Phosphodiesterase 3 Inhibitors
  • Pyridones
  • olprinone
  • Methylene Chloride
  • ethyl acetate